SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Tom Johnson who wrote (13547)7/14/2004 7:57:24 PM
From: DaveAu  Read Replies (1) | Respond to of 14101
 
Well it looks like WF10 is dead.

Russet was right!

What's the lesson ? No matter how good the phase 2 results are on small trials, they should be ignored. Wait for phase 3. Or better yet, invest in another industry. DMX isn't unique. Too few biotechs succeed. I only hold ONC and ISA now and I'm not much interested in looking at new biotechs. Seems to be a lot easier to make money in Oils and in Finance.

Dave



To: Tom Johnson who wrote (13547)7/25/2004 6:46:49 AM
From: E. T.  Respond to of 14101
 
Pennsaid was not prescribed. Celebrex was the doctor's drug of choice. The decision had to do with blood thinners she was taking. Pensaid, apparently, was contraindicated.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News